Sino Biological’s Sumana Sundaramurthy, Ph.D., discusses the tremendous potential of artificial intelligence (AI) to improve many aspects of drug development and other activities across biopharma and explains how Sino Biological is applying AI to antibody design to generate more effective vaccines and therapeutics.
.svg)
